Maravai LifeSciences Holdings, Inc. (MRVI)
| Previous close | 8.87 |
| Open | 9.14 |
| Bid | 8.70 x 200 |
| Ask | 9.90 x 200 |
| Day's range | 8.75 - 9.52 |
| 52-week range | 4.52 - 16.62 |
| Volume | |
| Avg. volume | 2,776,554 |
| Market cap | 2.359B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Maravai LifeSciences Reports First Quarter 2024 Financial Results
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific InnovationSAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2024, together with other business updates. Financial Highlights: Quarterly revenue of $64.2 million, Net loss of $(22.7) million, and Ad
- Business Wire
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
SAN DIEGO, April 30, 2024--TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
- Business Wire
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
SAN DIEGO, April 18, 2024--TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
